cyproterone acetate, ethinyl estradiol drug combination has been researched along with Insulin Resistance in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, P; Jiang, Z; Le, J; Lei, X; Tang, Q; Tu, H; Yao, J; Zhang, R; Zhang, S | 1 |
| Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L | 2 |
| Mohanty, J; Nagy, A; Sahu, A; Tripathy, P | 1 |
| Shi, Y; Tang, L; Ye, J; Zhu, X | 1 |
| de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Marcos, MV; Sebastiani, G | 1 |
| Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B | 1 |
| Aksoy, A; Carlioglu, A; Gozukara, I; Kabil Kucur, S; Kamalak, Z; Keskin, H; Uludag, EU | 1 |
| Chen, A; Du, J; Du, Y; Liao, YC; Lin, XF; Wang, Y; Wu, C; Wu, RR; Ye, Y; Zhang, XB | 1 |
| Jiang, M; Ma, F; Qi, J; Qiao, L; Wang, L; Xie, S; Xu, K; Yue, H; Zhang, W; Zhou, X | 1 |
| Demirlenk, S; Karabulut, A; Sevket, O | 1 |
| Mitkov, M; Pehlivanov, B; Terzieva, D | 1 |
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Lasunción, MA; Luque-Ramírez, M; Martínez-Bermejo, E | 1 |
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Luque-Ramírez, M; San Millán, JL; Sanchón, R | 1 |
6 trial(s) available for cyproterone acetate, ethinyl estradiol drug combination and Insulin Resistance
| Article | Year |
|---|---|
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome | 2018 |
Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Topics: Adult; Androgen Antagonists; Androgens; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Ovary; Polycystic Ovary Syndrome; Prospective Studies; Regional Blood Flow; Testosterone; Ultrasonography, Doppler, Color; Waist Circumference | 2019 |
Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
Topics: Adiposity; Adolescent; Adolescent Development; Androgen Antagonists; Body Mass Index; C-Reactive Protein; Carotid Intima-Media Thickness; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Menstruation Disturbances; Overweight; Tunica Intima; Vascular Diseases | 2013 |
Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Waist-Hip Ratio | 2005 |
Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Androgen Antagonists; Androgens; Blood Glucose; Cardiovascular Diseases; Cyproterone Acetate; Drug Combinations; Dyslipidemias; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Risk Factors | 2007 |
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Ferritins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iron; Metformin; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome | 2007 |
8 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and Insulin Resistance
| Article | Year |
|---|---|
Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
Topics: Androgen Antagonists; Animals; Apoptosis; Body Weight; Cyproterone Acetate; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Glycolysis; Hypoglycemic Agents; Insulin Resistance; Lactate Dehydrogenase 5; Luteinizing Hormone; Metformin; Ovary; Ovulation; Polycystic Ovary Syndrome; Pyruvate Kinase; Rats; Sirtuin 1; Testosterone | 2020 |
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult | 2018 |
Association between CD16
Topics: Adult; Biomarkers; Case-Control Studies; China; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Insulin Resistance; Metformin; Monocytes; Polycystic Ovary Syndrome; Prospective Studies; Receptors, IgG | 2019 |
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2014 |
How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Topics: Adolescent; Adult; Androgen Antagonists; Biomarkers; Blood Platelets; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Leukocyte Count; Mean Platelet Volume; Metformin; Polycystic Ovary Syndrome; Regression Analysis; Treatment Outcome | 2015 |
Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Topics: Abortion, Spontaneous; Adult; Androgen Antagonists; Blood Glucose; Body Mass Index; Clomiphene; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Live Birth; Luteinizing Hormone; Metformin; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2015 |
Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance.
Topics: Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Models, Biological; Ovarian Follicle; Ovary; Ovulation; Polycystic Ovary Syndrome; Sensitivity and Specificity | 2008 |
Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.
Topics: Adiposity; Adolescent; Adult; Androgen Antagonists; Body Fat Distribution; Carotid Intima-Media Thickness; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2012 |